<DOC>
	<DOCNO>NCT01975493</DOCNO>
	<brief_summary>The aim NAPPA develop new model improve understand child process ( 'metabolise ' ) penicillin , help u discover improve dose regimen use child future . The study population involve child neonate need penicillin antibiotic part normal National Health Service ( NHS ) care , also need blood test intravenous access . Therefore antibiotic study do without need extra invasive procedure , change medication therapy receive participant . In addition , NAPPA evaluate whether feasible measure antibiotic level tiny drop blood put onto absorbent paper ( `` dry blood spot '' ) . This allow sample store test later . NAPPA compare level antibiotic use method level measure usual way , show reliable method could use routinely future .</brief_summary>
	<brief_title>Neonatal Paediatric Pharmacokinetics Antimicrobials Study</brief_title>
	<detailed_description />
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Child age 16 year receive one specify penicillins intravenous access blood test ( ) part routine clinical care . Informed consent form sign parent legal guardian . Any child infant unlikely survive 48 hour recruitment . Patient know pregnant . Known allergy hypersensitivity betalactam antibiotic ( include penicillin cephalosporin ) betalactamase inhibitor . Patient receiving ( plan receive ) haemofiltration , haemodialysis , peritoneal dialysis , extracorporeal membrane oxygenation ( ECMO ) cardiopulmonary bypass .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Infectious Diseases</keyword>
	<keyword>Paediatrics</keyword>
	<keyword>Neonatology</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Antimicrobials</keyword>
</DOC>